ELASMOGEN LIMITED

Active Foresterhill

Research and experimental development on biotechnology

17 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

ELASMOGEN LIMITED

Research and experimental development on biotechnology

Founded 15 Jan 2014 Active Foresterhill, United Kingdom 17 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

PACIFIC SHELF 1760 LIMITED 15 Jan 2014 — 5 Feb 2014
Accounts Submitted 7 May 2025 Next due 31 Oct 2026 6 months remaining
Confirmation Submitted 3 Feb 2026 Next due 29 Jan 2027 9 months remaining
Net assets £3M £2M 2024 year on year
Total assets £3M £2M 2024 year on year
Total Liabilities £283K £205K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Liberty Building Foresterhill Aberdeen AB25 2ZP

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ELASMOGEN LIMITED (SC467513), an active life sciences and medical technology company based in Foresterhill, United Kingdom. Incorporated 15 Jan 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£2.31M

Decreased by £1.68M (-42%)

Net Assets

£2.81M

Decreased by £1.68M (-37%)

Total Liabilities

£282.86k

Decreased by £204.51k (-42%)

Turnover

N/A

Employees

17

Decreased by 1 (-6%)

Debt Ratio

9%

Decreased by 1 (-10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 4

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2016Seed
Investor 7Mar 2017Seed
Investor 8Mar 2017Seed

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 1,354,526 Shares £10.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Apr 20221,059,771£8.00m£7.549
29 Apr 202235,031£225k£6.416
28 Apr 202120,309£150k£7.37
31 Mar 202138,243£282k£7.37
24 Feb 202120,484£151k£7.37

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (15)

Kcp Nominees Ltd
20.4%
602,373
Bgf Nominees Limited (a/c Bgf Investments Lp)
15.7%
463,650

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 29 Apr 2022
Nature of Control
  • Significant Influence Or Control

Caroline Jane Barelle

Ceased 2 Jan 2018

Ceased

Kcp Nominees Ltd

Ceased 29 Apr 2022

Ceased

Group Structure

Group Structure

ELASMOGEN LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-15 with updates
28 Jan 2026OfficersTermination of Lucy Edwardes-Jones as director on 2026-01-15
7 May 2025AccountsAnnual accounts made up to 2025-01-31
16 Jan 2025Confirmation StatementConfirmation statement made on 2025-01-15 with updates
3 Jul 2024AccountsAnnual accounts made up to 2024-01-31
3 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-15 with updates

28 Jan 2026 Officers

Termination of Lucy Edwardes-Jones as director on 2026-01-15

7 May 2025 Accounts

Annual accounts made up to 2025-01-31

16 Jan 2025 Confirmation Statement

Confirmation statement made on 2025-01-15 with updates

3 Jul 2024 Accounts

Annual accounts made up to 2024-01-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-15 with updates

2 months ago on 3 Feb 2026

Termination of Lucy Edwardes-Jones as director on 2026-01-15

2 months ago on 28 Jan 2026

Annual accounts made up to 2025-01-31

11 months ago on 7 May 2025

Confirmation statement made on 2025-01-15 with updates

1 years ago on 16 Jan 2025

Annual accounts made up to 2024-01-31

1 years ago on 3 Jul 2024